1) at least some data on paternal exposure were available, 2) accumulated clinical experience of paternal exposure could guide the recommendation, or 3) there were no data on paternal exposure, but maternal exposure demonstrates teratogenicity. We do not present recommendations for new medications with no available class-level or drug-specific data. We strongly recommend against use of CYC and thalidomide in men prior to attempting conception. Paternal use of CYC may impair spermatogenesis or